Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver disease
- 1 April 1992
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 7 (2) , 225-231
- https://doi.org/10.1111/j.1440-1746.1992.tb00966.x
Abstract
The alterations in the concentration and composition of lipoproteins that occur in liver disease indicate the central role of the liver in lipoprotein metabolism. A number of studies have characterized plasma lipoproteins in patients with liver disease, although in most cases the underlying molecular defects responsible for the changes are still undetermined.Keywords
This publication has 37 references indexed in Scilit:
- CyclosporineNew England Journal of Medicine, 1989
- Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.Journal of Clinical Investigation, 1989
- Preclinical evaluation of lovastatinThe American Journal of Cardiology, 1988
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1984